ArticleBioImpacts : BI2025

Targeting immune checkpoints as a new therapeutic strategy for intra-hepatic cholangiocarcinoma.

Eman G Khedr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.